Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the disease-free survival in patients with locally
advanced rectal cancer treated with preoperative chemoradiotherapy with fluoropyrimidines and
surgery followed by adjuvant combination chemotherapy with oxaliplatin/5-FU/Leucovorin vs
5-FU/Leucovorin.